"This is a dark day for public health, especially for reproductive rights and the reliance on science and medical expertise to guide decisions about what drugs are safe and effective and should be available to patients," said Abby Long, Danco's Director of Public Affairs. Danco affirmatively joined the case as a defendant to protect the availability of Mifeprex for pregnant women and the company's only product, recognizing the importance of mifepristone as the only drug approved for medication abortion. Danco is the manufacturer of Mifeprex, the branded drug product approved for use in medical abortion and the reference product for generic mifepristone.
0 Comments
Leave a Reply. |